Literature DB >> 31082390

Hypoactivity of the lateral habenula contributes to negative symptoms and cognitive dysfunction of schizophrenia in rats.

Jicheng Li1, Shaojun Yang1, Xiaofeng Liu2, Yuliang Han3, Yanhui Li1, Jingjing Feng1, Hua Zhao4.   

Abstract

Dopaminergic (DAergic) hypofunction in the medial prefrontal cortex (mPFC) has been implicated in the negative and cognitive symptoms of schizophrenia and is regulated by serotonergic (5-HTergic) neurons in the dorsal raphe nucleus (DRN). The lateral habenula (LHb) is a key element in controlling DRN 5-HT neurons. We investigated how the LHb impacts the activity of mPFC neurons and whether it mediates the involvement of DRN on development of symptoms in a pharmacological animal model of schizophrenia. We used immunohisochemistry to assess cytochrome-c oxidase (COX) activity of the LHb in MK-801 model rats and extracellular firing recording to compare firing rates in LHb neurons of acute MK-801-treated rats. The sucrose preference, social interaction, and radial arm maze tests were used to access schizophrenia-like behavior in rats with electrolytically lesioned LHb. Finally, we examined levels of the dopamine D1 receptor (D1R) and tyrosine hydroxylase (TH) in the mPFC, and tryptophan hydroxylase 2 (TPH2) in the DRN of rats with LHb lesions to determine the possible mechanism underlying the schizophrenia-like behavior associated with lesioned LHb. We found that COX levels and LHb neuron firing rates decreased significantly in MK-801-treated animals. The LHb lesions induced negative and cognitive, but not positive symptoms of schizophrenia. The D1R and TH levels decreased in the mPFC while TPH2 expression elevated in the DRN and mPFC of LHb-lesioned rats. These results suggest that LHb hypoactivity may contribute to the negative and cognitive symptoms of schizophrenia by downregulating D1R expression in the mPFC, which might be mediated by DRN 5-HT neurons.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Dorsal raphe nucleus; Lateral habenula; Medial prefrontal cortex; Schizophrenia; Serotonin

Mesh:

Substances:

Year:  2019        PMID: 31082390     DOI: 10.1016/j.expneurol.2019.05.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Editorial: The Habenula and Its Role in Neuropsychiatric Symptoms.

Authors:  Flavia Venetucci Gouveia; Phillip Michael Baker; Manuel Mameli; Jurgen Germann
Journal:  Front Behav Neurosci       Date:  2022-05-24       Impact factor: 3.617

2.  Response Flexibility: The Role of the Lateral Habenula.

Authors:  Victoria I Hones; Sheri J Y Mizumori
Journal:  Front Behav Neurosci       Date:  2022-04-04       Impact factor: 3.617

Review 3.  The effects and mechanism of environmental enrichment on MK-801 induced cognitive impairment in rodents with schizophrenia.

Authors:  Jinwei Xu; Yaohao Li; Biqing Tian; Haiying Liu; Shengxi Wu; Wenting Wang
Journal:  Front Cell Neurosci       Date:  2022-09-29       Impact factor: 6.147

4.  The Habenula in the Link Between ADHD and Mood Disorder.

Authors:  Young-A Lee; Yukiori Goto
Journal:  Front Behav Neurosci       Date:  2021-06-24       Impact factor: 3.558

5.  Acute MPTP Treatment Impairs Dendritic Spine Density in the Mouse Hippocampus.

Authors:  Poornima D E Weerasinghe-Mudiyanselage; Mary Jasmin Ang; Mai Wada; Sung-Ho Kim; Taekyun Shin; Miyoung Yang; Changjong Moon
Journal:  Brain Sci       Date:  2021-06-23

6.  Altered resting-state functional connectivity and effective connectivity of the habenula in irritable bowel syndrome: A cross-sectional and machine learning study.

Authors:  Cui P Mao; Fen R Chen; Jiao H Huo; Liang Zhang; Gui R Zhang; Bing Zhang; Xiao Q Zhou
Journal:  Hum Brain Mapp       Date:  2020-06-03       Impact factor: 5.038

7.  Lateral habenula dysfunctions in Tm4sf2-/y mice model for neurodevelopmental disorder.

Authors:  Luca Murru; Luisa Ponzoni; Anna Longatti; Sara Mazzoleni; Giorgia Giansante; Silvia Bassani; Mariaelvina Sala; Maria Passafaro
Journal:  Neurobiol Dis       Date:  2020-11-20       Impact factor: 5.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.